New hope for drug to help with spinal injuries

Dr. Swarna Balasubramanian, Chemical and Biochemical Engineering PhD '14, is the Associate Director of Emerging Innovations at AstraZeneca. She received exciting news stemming from her 2014 prize about treatments for spinal cord injury from the Open Innovation Program at AstraZeneca. Her ideas were followed up by AstraZeneca in collaboration with University of Birmingham -- preclinical work showing its promise has been published in Clinical and Translational Medicine.  Dr. Balasubramanian's PhD mentor was Dr. Jennie Leach.